NASDAQ:OSUR - OraSure Technologies Stock Price, Forecast & News

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

OraSure Technologies, Inc. (NASDAQ:OSUR) posted its earnings results on Wednesday, November, 6th. The medical instruments supplier reported $0.21 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.03 by $0.18. The medical instruments supplier had revenue of $35.99 million for the quarter, compared to analyst estimates of $38.62 million. OraSure Technologies had a net margin of 15.80% and a return on equity of 5.93%. OraSure Technologies's revenue was down 21.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.13 EPS. View OraSure Technologies' Earnings History.

OraSure Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for OraSure Technologies.

OraSure Technologies issued an update on its FY19 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of $0.28-0.31 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.32. The company issued revenue guidance of $150-153 million, compared to the consensus revenue estimate of $162.58 million.

1 brokerages have issued 1-year target prices for OraSure Technologies' shares. Their forecasts range from $8.00 to $8.00. On average, they anticipate OraSure Technologies' stock price to reach $8.00 in the next year. This suggests a possible upside of 0.8% from the stock's current price. View Analyst Price Targets for OraSure Technologies.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for OraSure Technologies.

Headlines about OSUR stock have trended somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. OraSure Technologies earned a news impact score of 2.0 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for OraSure Technologies.

Some companies that are related to OraSure Technologies include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), XOMA (xoma), Energy Transfer LP Unit (ET), Overstock.com (OSTK), Ford Motor (F), CBL & Associates Properties (CBL), Celldex Therapeutics (CLDX), SandRidge Permian Trust (PER) and ABIOMED (ABMD).

OraSure Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.48%), First Hawaiian Bank (0.13%), Alpine Global Management LLC (0.05%), Louisiana State Employees Retirement System (0.03%) and Lenox Wealth Advisors LLC (0.01%). Company insiders that own OraSure Technologies stock include Brian Smith, Charles W Patrick, Jack E Jerrett, Roberto Cuca and Stephen S Phd Tang. View Institutional Ownership Trends for OraSure Technologies.

OSUR stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., First Hawaiian Bank and Louisiana State Employees Retirement System. View Insider Buying and Selling for OraSure Technologies.

OSUR stock was purchased by a variety of institutional investors in the last quarter, including Alpine Global Management LLC and Lenox Wealth Advisors LLC. Company insiders that have bought OraSure Technologies stock in the last two years include Jack E Jerrett, Roberto Cuca and Stephen S Phd Tang. View Insider Buying and Selling for OraSure Technologies.

Shares of OSUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OSUR stock can currently be purchased for approximately $7.94.

OraSure Technologies has a market capitalization of $490.14 million and generates $181.74 million in revenue each year. The medical instruments supplier earns $20.40 million in net income (profit) each year or $0.50 on an earnings per share basis. OraSure Technologies employs 398 workers across the globe.View Additional Information About OraSure Technologies.

The official website for OraSure Technologies is http://www.orasure.com/.

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The medical instruments supplier can be reached via phone at 610-882-1820 or via email at [email protected]